Turenne Groupe, via FPCI Capital Santé 2 as lead and Nord Capital Investissement, is entering Interor’s capital, accompanied by Bpifrance.
Today it has been announced that Chemspec Europe will be once again postponed and will now take place from 19 – 20 May 2021 at Frankfurtmesse in Germany, due to COVID-19.
DECLARATION OF INTENT
On 14th June 2018, Cefic and ECHA signed a Joint Statement whereby they agreed to cooperate to promote a gradual and planned improvement of the quality of the REACH registration dossiers and identify (groups of) specific substances, or scientific and technical challenges, which require expert discussion.
Cefic has developed a REACH Action Plan for Review / Improvement of Registration Dossiers to encourage and support companies in evaluating existing registration dossiers and implement follow up actions, while keeping close contact with ECHA and its strategy.
This declaration is to confirm that, in full compliance with competition law and within the context of the mentioned REACH Action Plan for Review / Improvement of Dossiers [Version 1, 26 June 2019], INTEROR intends in its own discretion and in line with REACH requirements to:
- Take steps to review the quality of its REACH registration dossiers and provide further information, where appropriate.
- Provide on an annual basis to Cefic the data listed in the CEFIC Reporting Template and authorises Cefic to publicly report on the REACH registration dossiers reviews, on an aggregated and anonymised basis.
Signed by Jean-Pierre GUILLOT (REACH Coordinator) on June 8, 2020
INTEROR manufactures and sells very important and vital synthesis intermediates for the pharmaceutical industry.
In this difficult context we have implemented numerous measures to allow the continuity of production by minimizing as much as possible the risks incurred by our employees such as alternating shifts, delayed arrivals, etc., barrier gestures in compliance with the directives of the French government and the legal framework in force.
However, we plan to partially reduce our activity due to the work disrupted by the imposition of the various barriers and the time needed by the teams for regular disinfection.
Pharmaceutical intermediates will be maintained as a priority, aiming at a correct percentage of the initial order, but new orders for Q2 will not be accepted unless there is a health emergency.
However, we need all the support of our suppliers to provide the essential raw materials on our site, and of our partners to continue the necessary services entrusted by us, otherwise our activity would be slowed down.
We thank our suppliers for their involvement and our customers for their understanding in this unprecedented context.
Please do not hesitate to contact us for any further explanations.
Interor will be present at CPhI Worldwide 2019 from 5 to 7 November at Messe of Francfort.
Our booth will be 61D13 on the French Pavilion (SICOS).
If you are willing to meet us there, please feel free to contact us using the contact form. See you in Francfort.
Interor will be present at Chemspec Europe 2019 from 26 to 27 June at Messe Basel, Switzerland. Our booth will be CS/F101. If you are willing to meet us there, please feel free to contact us using the contact form.
Interor will be present at CPhI Worldwide 2018 from 9 to 11 October at Feria de Madrid, Spain CPhI.
Our booth will be 10F40 on the French Pavilion (SICOS).
If you are willing to meet us there, please feel free to contact us using the contact form.
See you in Madrid.